Use of Structure-Based Design to Discover a Potent, Selective, In Vivo Active Phosphodiesterase 10A Inhibitor Lead Series for the Treatment of Schizophrenia

被引：49

作者：

Helal, Christopher J. ^{[1
]}

Kang, Zhijun ^{[1
]}

Hou, Xinjun ^{[1
]}

Pandit, Jayvardhan ^{[1
]}

Chappie, Thomas A. ^{[1
]}

Humphrey, John M. ^{[1
]}

Marr, Eric S. ^{[1
]}

Fennell, Kimberly F. ^{[1
]}

Chenard, Lois K. ^{[1
]}

Fox, Carol ^{[1
]}

Schmidt, Christopher J. ^{[1
]}

Williams, Robert D. ^{[1
]}

Chapin, Douglas S. ^{[1
]}

Siuciak, Judith ^{[1
]}

Lebel, Lorraine ^{[1
]}

Menniti, Frank ^{[1
]}

Cianfrogna, Julia ^{[1
]}

Fonseca, Kari R. ^{[1
]}

Nelson, Frederick R. ^{[1
]}

O'Connor, Rebecca ^{[1
]}

MacDougall, Mary ^{[1
]}

McDowell, Laura ^{[1
]}

Liras, Spiros ^{[1
]}

机构：

[1] Pfizer Worldwide Res & Dev, Groton, CT 06340 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2011年 / 54卷 / 13期

关键词：

CENTRAL-NERVOUS-SYSTEM; P-GLYCOPROTEIN; III INHIBITOR; DRUGS; GENERATION; PDE10A; LIGAND; BRAIN;

D O I：

10.1021/jm2001508

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Utilizing structure-based virtual library design and scoring, a novel chimeric series of phosphodiesterase 10A (PDE10A) inhibitors was discovered by synergizing binding site interactions and ADME properties of two chemotypes. Virtual libraries were docked and scored for potential binding ability, followed by visual inspection to prioritize analogs for parallel and directed synthesis. The process yielded highly potent and selective compounds such as 16. New X-ray cocrystal structures enabled rational design of substituents that resulted in the successful optimization of physical properties to produce in vivo activity and to modulate microsomal clearance and permeability.

引用

页码：4536 / 4547

页数：12

共 50 条

[21] Metamorphosis of paroxetine into a highly potent and selective GRK2 inhibitor via structure-based drug design
Waldschmidt, Helen
Homan, Kristoff
Cruz-Rodriguez, Osvaldo
Cato, Marilyn
Bouley, Renee
Wilson, Michael
Cannavo, Alessandro
Song, Jianliang
Cheung, Joseph
Kirchhoff, Paul
Koch, Walter
Tesmer, John
Larsen, Scott
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
[22] Structure-based library design and the discovery of a potent and selective mast cell β-tryptase inhibitor as an oral therapeutic agent
Liang, Guyan
Aldous, Suzanne
Merriman, Gregory
Levell, Julian
Pribish, James
Cairns, Jennifer
Chen, Xin
Maignan, Sebastien
Mathieu, Magali
Tsay, Joseph
Sides, Keith
Rebello, Sam
Whitely, Brian
Morize, Isabelle
Pauls, Henry W.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (02) : 1049 - 1054
[23] Structure-Based Design of a Potent and Selective Covalent Inhibitor for SRC Kinase That Targets a P-Loop Cysteine
Du, Guangyan
Rao, Suman
Gurbani, Deepak
Henning, Nathaniel J.
Jiang, Jie
Che, Jianwei
Yang, Annan
Ficarro, Scott B.
Marto, Jarrod A.
Aguirre, Andrew J.
Sorger, Peter K.
Westover, Kenneth D.
Zhang, Tinghu
Gray, Nathanael S.
JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (04) : 1624 - 1641
[24] Structure-Based Design of a Novel Series of Potent, Selective Inhibitors of the Class I Phosphatidylinositol 3-Kinases
Smith, Adrian L.
D'Angelo, Noel D.
Bo, Yurain Y.
Booker, Shon K.
Cee, Victor J.
Herberich, Brad
Hong, Fang-Tsao
Jackson, Claire L. M.
Lanman, Brian A.
Liu, Longbin
Nishimura, Nobuko
Pettus, Liping H.
Reed, Anthony B.
Tadesse, Seifu
Tamayo, Nuria A.
Wurz, Ryan P.
Yang, Kevin
Andrews, Kristin L.
Whittington, Douglas A.
McCarter, John D.
Miguel, Tisha San
Zalameda, Leeanne
Jiang, Jian
Subramanian, Raju
Mullady, Erin L.
Caenepeel, Sean
Freeman, Daniel J.
Wang, Ling
Zhang, Nancy
Wu, Tian
Hughes, Paul E.
Norman, Mark H.
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (11) : 5188 - 5219
[25] Structure-Based Design and Discovery of a Potent and Cell-Active LC3A/B Covalent Inhibitor
Zhou, Zhenfei
Huang, Siqi
Fan, Shijie
Li, Xueyuan
Wang, Chengyu
Yu, Wanlin
Du, Daohai
Zhang, Yuanyuan
Chen, Kaixian
Fu, Wei
Luo, Cheng
JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (14) : 12184 - 12204
[26] Use of structure based design to increase selectivity of pyridyl-cinnoline phosphodiesterase 10A (PDE10A) inhibitors against phosphodiesterase 3 (PDE3)
Hu, Essa
Kunz, Roxanne K.
Rumfelt, Shannon
Andrews, Kristin L.
Li, Chun
Hitchcock, Stephen A.
Lindstrom, Michelle
Treanor, James
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (22) : 6938 - 6942
[27] Structure-based design of Trifarotene (CD5789), a potent and selective RARγ agonist for the treatment of acne
Thoreau, Etienne
Arlabosse, Jean-Marie
Bouix-Peter, Claire
Chambon, Sandrine
Chantalat, Laurent
Daver, Sebastien
Dumais, Laurence
Duvert, Gwenaelle
Feret, Angelique
Ouvry, Gilles
Pascau, Jonathan
Raffin, Catherine
Rodeville, Nicolas
Soulet, Catherine
Tabet, Samuel
Talano, Sandrine
Portal, Thibaud
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (10) : 1736 - 1741
[28] Discovery of an Orally Bioavailable, Brain-Penetrating, in Vivo Active Phosphodiesterase 2A Inhibitor Lead Series for the Treatment of Cognitive Disorders
Mikami, Satoshi
Sasaki, Shigekazu
Asano, Yasutomi
Ujikawa, Osamu
Fukumoto, Shoji
Nakashima, Kosuke
Oki, Hideyuki
Kamiguchi, Naomi
Imada, Haruka
Iwashita, Hiroki
Taniguchit, Takahiko
JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (18) : 7658 - 7676
[29] MEDI 361-Lead optimization and structure-based design of deoxycytidine kinase inhibitors with potent in vitro and in vivo activity
Jessop, Theodore C.
Tarver, James E., Jr.
Foushee, Ann Marie DiGeorge
Jhaver, Kanchan G.
Taylor, Jerry A.
Xu, Xiaolian
Fu, Qinghong
Carlsen, Marianne
Shen, Min
Yu, Xuan-Chuan
Liu, Ziye
Miranda, Maricar L.
NourAlDeen, Amr
Yu, Xiang-Qing
Tari, Leslie W.
Hunter, Michael J.
Hoffman, Issac D.
Wilson, Alan G. E.
Anderson, Stephen J.
Oravecz, Tamas
Stouch, Terry R.
Augeri, David J.
Carson, Kenneth G.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 236
[30] Structure-Based Drug Design of RN486, a Potent and Selective Bruton's Tyrosine Kinase (BTK) Inhibitor, for the Treatment of Rheumatoid Arthritis
Lou, Yan
Han, Xiaochun
Kuglstatter, Andreas
Kondru, Rama K.
Sweeney, Zachary K.
Soth, Michael
McIntosh, Joel
Litman, Renee
Suh, Judy
Kocer, Buelent
Davis, Dana
Park, Jaehyeon
Frauchiger, Sandra
Dewdney, Nolan
Zecic, Hasim
Taygerly, Joshua P.
Sarma, Keshab
Hong, Junbae
Hill, Ronald J.
Gabriel, Tobias
Goldstein, David M.
Owens, Timothy D.
JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (01) : 512 - 516

← 1 2 3 4 5 →